The “Large Volume Wearable Injectors Market (5th Edition), 2020-2030: Focus on Bolus

Market-Research

Key Inclusions

An overview of current market landscape of the large volume wearable injectors available for delivery of insulin and non-insulin drugs, providing information on status of development and device specifications, such as type of device (patch pump /

Submitted by Roots_Analysis on 2020-07-24 14:26.

More than 40 large volume wearable injectors are presently available / under development for the administration of drugs, beyond insulin, including 15+ drug-device combinations

Market-Research

The convenience of subcutaneous route of drug administration and the reformulation of intravenous drugs, reaching patent expiry, for SC delivery has provided an impetus to the development of large volume wearable injectors. In fact, according to the experts in this field, the industry is putting ... Read more

Submitted by Roots_Analysis on 2020-07-24 14:22.

The large volume wearable injectors market is projected to grow at an annualized rate of ~35%, till 2030

Market-Research

Roots Analysis has done a detailed study on Large Volume Wearable Injectors Market (5th Edition), 2020-2030: Focus on ... Read more

Submitted by Roots_Analysis on 2020-07-24 14:18.

The large volume wearable injectors market is estimated to be worth around USD 600 million by 2030, predicts Roots Analysis

Market-Research

Large Volume Wearable Injectors have made it convenient to self-administer drugs in the home care setting, providing substantial cost benefits, improving medication adherence and reducing the risk of dosing errors, microbial contamination and needle-stick injuries; in fact, these ... Read more

Submitted by Roots_Analysis on 2020-07-24 14:13.

The “Live Biotherapeutic Products and Microbiome Contract Manufacturing Market: Focus on Active Pharmaceutical Ingredients and Finished Dosage Forms, 2020-2030” report features an extensive study of the current landscape and future opportunities related t

Market-Research

Key Inclusions

A detailed review of the overall landscape of companies offering contract services for manufacturing of microbiome therapeutics, including information on year of establishment, company size, scale of operation (preclinical, clinical and commercial

Submitted by Roots_Analysis on 2020-07-23 11:07.

The microbiome therapies pipeline features 260 drugs under evaluation across different phases of development

Market-Research

Manufacturing live biotherapeutic products is both technically challenging and financially demanding; as a result, innovator firms are becoming increasingly reliant on contract service providers to access specialized facilities and optimize overall costs.

Submitted by Roots_Analysis on 2020-07-23 11:03.

The contract manufacturing market for live biotherapeutics and microbiome products is estimated to be worth USD 300 million by 2030, growing at a CAGR of 46%, claims Roots Analysis

Market-Research

Roots Analysis has done a detailed study on Live Biotherapeutic Products and Microbiome Contract Manufacturing Market, 2020-2030: Focus on Active ... Read more

Submitted by Roots_Analysis on 2020-07-23 10:57.

The contract manufacturing market for live biotherapeutics and microbiome products is estimated to be worth USD 300 million by 2030, growing at a CAGR of 46%, claims Roots Analysis

Market-Research

Manufacturing live biotherapeutic product is both technically challenging and financially demanding; as a result, innovator firms are becoming increasingly reliant on contract service providers to access specialized facilities and optimize overall costs.

Submitted by Roots_Analysis on 2020-07-23 10:52.

The ‘Blood-Brain Barrier (BBB) Market, 2020-2030: Focus on Non-Invasive Drug

Market-Research

Key Inclusions

An overview of the overall landscape of BBB penetration technologies, featuring an in-depth analysis of the technologies based on a number of parameters, such as status of development (developed and under development), affiliated approach, type of

Submitted by Roots_Analysis on 2020-07-23 10:46.

More than 110 drugs, capable of penetrating this elusive barrier are currently being evaluated for the treatment of CNS disorders

Market-Research

The concept of BBB penetration is anticipated to bring about a paradigm shift in modern healthcare. In fact, experts believe that there is an important relationship between the recent pandemic of Coronavirus disease (COVID-19) and cerebrovascular system, presenting commercial opportunities for ... Read more

Submitted by Roots_Analysis on 2020-07-23 10:24.

The BBB penetrating drugs market is projected to grow at an annualized rate of ~154%, till 2030

Market-Research

Roots Analysis has done a detailed study on Blood-Brain Barrier (BBB) Market (2nd Edition), 2020-2030: Focus on Non-Invasive Drug ... Read more

Submitted by Roots_Analysis on 2020-07-23 10:13.

The blood-brain barrier (BBB) penetrating drugs market is estimated to be worth USD 900 million in 2030, predicts Roots Analysis

Market-Research

Advances in biotechnology have enabled the development of versatile in vitro (static and dynamic), in vivo (micro-dialysis), and in situ (brain perfusion) blood–brain barrier models, allowing more effective and safe delivery of drugs across brain capillaries

Submitted by Roots_Analysis on 2020-07-23 10:05.

The “Bispecific Antibody Therapeutics Market (4th Edition), 2019-2030” report

Market-Research

Key Inclusions

§ A detailed review of the overall landscape of bispecific antibody therapeutics, including information on drug developers, phase of development (marketed, clinical, and preclinical / discovery) of the pipeline ... Read more

Submitted by Roots_Analysis on 2020-07-23 09:56.

With two approved drugs and close to 300 clinical / preclinical product candidates, the bispecific antibody therapeutics pipeline has evolved significantly over the past few years, claims Roots Analysis

Market-Research

With various target combinations and novel mechanisms of action, bispecific antibodies are presently recognized as a potent class of targeted therapies, with the potential to be used as treatment options for a variety of disease indications. Several pipeline candidates have recently entered mid ... Read more

Submitted by Roots_Analysis on 2020-07-23 09:36.

The bispecific antibody therapeutics market is projected to grow at an annualized rate of ~16%, in the span of 2019 to 2030

Market-Research

Roots Analysis has done a detailed study on Bispecific Antibody Therapeutics Market (4^th Edition), 2020-2030, covering key aspects of the ... Read more

Submitted by Roots_Analysis on 2020-07-23 09:29.

The bispecific antibody therapeutics market is estimated to be worth USD 6.9 billion in 2030, predicts Roots Analysis

Market-Research

Bispecific antibody therapeutics represent a transformative approach to modern treatment; over the years, this upcoming class of ‘two-target’ artificially engineered drugs have generated significant enthusiasm within the medical science community

Submitted by Roots_Analysis on 2020-07-23 09:18.

The “Peptides and Macrocycle Drug Discovery: Services and Platforms Market, 2020-2030” report

Market-Research

Key Inclusions

A detailed assessment of the current market landscape of companies offering peptide and macrocycle drug discovery services, including developer information (year of establishment, company size and location of headquarters), type of peptide

Submitted by Roots_Analysis on 2020-07-22 11:31.

More than 35 industry players claim to offer services for the identification, characterization and development of peptides and macrocycle-based pharmacological lead candidates, claims Roots Analysis

Market-Research

Drug discovery is challenging and involves several complexities. In order to continue to add new molecules their pipelines, drug developers are opting to outsource such operations to contract research organizations (CROs). Outsourcing of peptides and macrocycle drug discovery has emerged as one ... Read more

Submitted by Roots_Analysis on 2020-07-22 11:25.

The next generation immune checkpoint inhibitors and stimulators market is projected to grow at an annualized rate of ~10.5%, till 2030

Market-Research

Roots Analysis has done a detailed study on Peptides and Macrocycle Drug Discovery: Services and Platforms Market, 2020-2030, covering key ... Read more

Submitted by Roots_Analysis on 2020-07-22 11:20.

The peptides and macrocycle drug discovery services market is estimated to be worth USD 1.5 billion in 2030, predicts Roots Analysis

Market-Research

Given the recent developments in healthcare, supporting safety and efficacy of peptide and affiliated macrocycle drugs, the industry is presently witnessing an increase in discovery and development initiatives related to such therapeutic modalities.

Submitted by Roots_Analysis on 2020-07-22 11:12.

Pages